Dipeptidyl peptidase‐4 inhibitor, anagliptin, alters hepatic insulin clearance in relation to the glycemic status in Japanese individuals with type 2 diabetes

AIMS/INTRODUCTION: This study investigated the impact of the dipeptidyl peptidase‐4 inhibitor, anagliptin, on hepatic insulin clearance (HIC) in Japanese type 2 diabetes patients and explored its relationship to glycemic status. MATERIALS AND METHODS: Data on 765 participants in anagliptin phase 2 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Takahiro, Matsubayashi, Yasuhiro, Muragishi, Sayaka, Yoshida, Akihiro, Suganami, Hideki, Furusawa, Kenichi, Fujihara, Kazuya, Tanaka, Shiro, Kaku, Kohei, Sone, Hirohito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504901/
https://www.ncbi.nlm.nih.gov/pubmed/33751849
http://dx.doi.org/10.1111/jdi.13543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504901/
https://www.ncbi.nlm.nih.gov/pubmed/33751849
http://dx.doi.org/10.1111/jdi.13543

Ejemplares similares